THE KPM GROUP DC LLC

Lobbying for SOLENO THERAPEUTICS, INC. · Soleno is focused on development of novel therapeutics for treatment of rare diseases.

Filing 2nd Quarter - Amendment

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 28, 2026

Income

$10,000.00

What the client paid this registrant for the period.

Client based in

California

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 4

Lobbying activity 1

Health Issues

HR 5509/S.2903 Safe Step Act HR 6423/S. 864 HELP Copays Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.